US Grants AstraZeneca's Lynparza Priority Review For Prostate Cancer Read More
UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight Read More
TOP NEWS: Astra Ends Epanova Trial; Lynparza Gets US Priority Review Read More
LONDON BRIEFING: AstraZeneca To Take Hit After Epanova Trial Halted Read More
UK BROKER RATINGS SUMMARY: Bank Of America Downgrades Morrisons Read More
TOP NEWS: Astra's Lokelma Approved In China, Farxiga Gets FDA Review Read More
LONDON MARKET PRE-OPEN: AstraZeneca Gets Positive News In US And China Read More
TOP NEWS: Astra, Merck & Co's Lynparza Approved For Cancer Treatment Read More
LONDON MARKET PRE-OPEN: Astra's Lynparza Approved; Rio Restarts RBM Read More
AstraZeneca's Triple-Combination Therapy Approved In China Read More
US FDA Approves AstraZeneca Breast Cancer Treatment Enhertu Read More
LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote Read More
LONDON MARKET OPEN: Shell Dips After Warning Over Earnings Hit Read More
AstraZeneca Sells Two Cancer Drug Rights For Up To USD198 Million Read More
LONDON MARKET PRE-OPEN: AstraZeneca Sells Cancer Drug Rights Read More
AstraZeneca Says Lynparza Recommended By FDA For Pancreatic Cancer Read More
UK BROKER RATINGS SUMMARY: JPMorgan Cuts Rio And BHP, Raises Anglo Read More
AstraZeneca Divests Seroquel, Seroquel XR Rights In Europe And Russia Read More
UK BROKER RATINGS SUMMARY: Bank Of America Upgrades HSBC To Buy Read More
AstraZeneca Receives Marketing Authorization In China For Imfinzi Read More
